[HTML][HTML] Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

M Levine-Tiefenbrun, I Yelin, R Katz, E Herzel… - Nature medicine, 2021 - nature.com
M Levine-Tiefenbrun, I Yelin, R Katz, E Herzel, Z Golan, L Schreiber, T Wolf, V Nadler…
Nature medicine, 2021nature.com
Beyond their substantial protection of individual vaccinees, coronavirus disease 2019
(COVID-19) vaccines might reduce viral load in breakthrough infection and thereby further
suppress onward transmission. In this analysis of a real-world dataset of positive severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test results after inoculation with
the BNT162b2 messenger RNA vaccine, we found that the viral load was substantially
reduced for infections occurring 12–37 d after the first dose of vaccine. These reduced viral …
Abstract
Beyond their substantial protection of individual vaccinees, coronavirus disease 2019 (COVID-19) vaccines might reduce viral load in breakthrough infection and thereby further suppress onward transmission. In this analysis of a real-world dataset of positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test results after inoculation with the BNT162b2 messenger RNA vaccine, we found that the viral load was substantially reduced for infections occurring 12–37 d after the first dose of vaccine. These reduced viral loads hint at a potentially lower infectiousness, further contributing to vaccine effect on virus spread.
nature.com